Product Information
KEPPRA 250 MG TABLET is a brand product labeled by UCB, Inc., priced at $8.0452 per EA under NDC 50474059440. Its NADAC has been published 649 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the levetiracetam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
UCB, Inc.NDC
50474059440
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVETIRACETAMApproval Type
New Drug (NDA)
FDA Application
NDA021035On Market Since
4/24/2000
Pharmacological Classes
Price Statistics
The NADAC for KEPPRA 250 MG TABLET has been published 649 times since Nov 28, 2013, and over the history we have for it it has risen 75.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0452 per EA |
|---|---|
| All-time high | $8.1159 (Jun 10, 2026) |
| All-time low | $4.5935 (Nov 28, 2013) |
| 52-week high | $8.1159 |
| 52-week low | $7.8982 |
| Median price | $6.3604 |
| Average price | $6.5061 |
| Largest weekly change | +9.9% (Jan 8, 2014) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KEPPRA 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KEPPRA 250 MG TABLET, manufactured by UCB, Inc., is $8.0452 per EA (NDC 50474059440), effective Jun 24, 2026.
How has the price of KEPPRA 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for KEPPRA 250 MG TABLET has risen 75.1%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KEPPRA 250 MG TABLET?
Since Nov 28, 2013, the NADAC for KEPPRA 250 MG TABLET has ranged from a low of $4.5935 (Nov 28, 2013) to a high of $8.1159 (Jun 10, 2026), with a median of $6.3604 per EA.
Are there cheaper alternatives to KEPPRA 250 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as KEPPRA 250 MG TABLET, but none are currently priced below it.
Who manufactures KEPPRA 250 MG TABLET?
KEPPRA 250 MG TABLET (NDC 50474059440) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification